2007
DOI: 10.1177/0883073807310988
|View full text |Cite
|
Sign up to set email alerts
|

Major Adverse Events Associated With Treatment of Infantile Spasms

Abstract: Few studies have focused on tolerability and adverse events associated with natural adrenocorticotropic hormone injections for treatment of infantile spasms. Using a retrospective chart review of 130 patients, the authors compare major adverse events, weight and blood pressure changes, and unplanned medication changes associated with adrenocorticotropic hormone (ACTH) injections versus other antiepileptic drugs. Children treated with adrenocorticotropic hormone injections experienced significant short-term wei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 30 publications
1
20
1
Order By: Relevance
“…ACTH is given using intramuscular injection. Effective short-duration treatment may avoid major side effects associated with IS treatment [41]. The most frequent adverse effects associated with short-duration ACTH treatment are irritability, increased appetite leading to weight gain [39], and Cushingoid features.…”
Section: Resultsmentioning
confidence: 99%
“…ACTH is given using intramuscular injection. Effective short-duration treatment may avoid major side effects associated with IS treatment [41]. The most frequent adverse effects associated with short-duration ACTH treatment are irritability, increased appetite leading to weight gain [39], and Cushingoid features.…”
Section: Resultsmentioning
confidence: 99%
“…Developmental outcomes are unclear, and it is not known if treatment produces a partial response in spasms and hypsarrhythmia. Effective short‐duration treatment may avoid major side effects associated with first‐ and second‐line treatments for IS (Partikian & Mitchell, 2007). Timely management of patients who are refractory to first‐line therapy is critical (Hrachovy & Frost, 2003; Lux & Osborne, 2004).…”
Section: Therapeutic Options For Ismentioning
confidence: 99%
“…These include weight and blood pressure changes, infections, also with opportunistic organism, hyperglycemia and electrolyte abnormalities, cushingoid appearance, development of new seizure types, sleep and behaviour abnormalities and decrease of bone density sometimes with fractures, skin rashes with intravascular coagulation and even death. In the referred studies doses of ACTH were however mostly superior to 150 U/square m/day [97,98]. For this reason a much lower dosage and shorter treatment have recently been utilized.…”
Section: Treatmentmentioning
confidence: 99%